Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse

项目概要/摘要 由于药物滥用的发病率和社会成本增加， 对药物滥用的反应（DOA）特别令人感兴趣 并可能为治疗开发提供潜在的新靶点。然而，生物医学领域的一个重大挑战是， 科学正在确定群体内的遗传差异如何影响特性（即表型，性状） 一个人的。使用传统的方法，它往往需要多年的艰苦工作来发现， 表征影响给定表型反应的遗传变体。几年前，我们开发了一个 一种更有效的将基因映射到性状的方法，称为基于单体型的计算遗传作图 （HBCGM）。 因为这将有助于识别高危人群 在HBCGM实验中，在近交系小鼠品系中测量感兴趣的性质;并且遗传学上， 通过识别遗传变异模式的基因组区域， 与品系间性状值的分布相关。HBCGM分析的完成要多得多 比传统的基因分析方法更快。然而，用于实验验证的方法 遗传因素具有局限性并且是耗时的。 该项目将进一步开发计算方法，使遗传因素影响许多 重要的生物医学特性有待发现和实验表征。高通量版本的 HBCGM（HT-HBCGM）将用于分析8，225个公开可用的数据集，其中测量213，000个 在近交系小鼠品系的面板中的响应。我们采用了一种新颖的方法， 增加基因发现 通过利用存在于检查类似响应的许多数据集中的冗余来提供功率。小说 促进遗传、转录和代谢组学数据的综合分析的计算工具将 也要发展。这包括 专门的代谢网络（用于大脑和其他3种组织）， 计算鉴定与基因表达或遗传差异相关的代谢组学变化。到 鼓励其他研究人员进行基因发现，该项目的所有结果和方法将被 向科学界全面开放。这些计算工具将用于分析定制的 “多组学”（遗传、转录和代谢组学）数据集，测量：（一）近交系的15种反应 应变面板到四个DOA（可卡因，甲基苯丙胺，芬太尼，尼古丁）;和（ii）相应的DOA- 在大脑中诱导转录和代谢组学变化。对这些数据的综合分析将确定 影响对DOA反应的基因/途径。 然后，我们应用一种高效的方法，工程 将特定等位基因改变引入近交品系的基因组中，并且将工程化品系用于实验性地 测试已识别的遗传因素对DOA反应的影响。

Project Summary/Abstract Due to the increased morbidity and societal cost of drug abuse, identification of genetic factors affecting the response to drugs of abuse (DOA) are of particular interest and could provide potential novel targets for therapeutic development . However, a major challenge in biomedical science is determining how genetic differences within a population affect the properties (i.e. phenotypes, traits) of an individual. Using conventional methods, it often requires years of painstaking work to discover and characterize a genetic variant that affects a given phenotypic response. Several years ago, we developed a more efficient method for mapping genes to traits, called haplotype-based computational genetic mapping (HBCGM). because this will aid in identifying at risk populations In an HBCGM experiment, a property of interest is measured in inbred mouse strains; and genetic factors are computationally predicted by identifying the genomic regions where the pattern of genetic variation correlates with the distribution of trait values among the strains. HBCGM analyses are completed much more quickly than conventional genetic analysis methods. However, the methods used for experimental validation of genetic factors have limitations and are time consuming. This project will further develop computational methods that will enable genetic factors affecting many important biomedical traits to be discovered and experimentally characterized. A high-throughput version of HBCGM (HT-HBCGM) will be used to analyze 8,225 publicly available datasets, which measure 213,000 responses in panels of inbred mouse strains. We deploy a novel method that increases genetic discovery power by exploiting the redundancy present in the many datasets that examine similar responses. Novel computational tools that facilitate the integrated analysis of genetic, transcriptional and metabolomic data will also be developed. This includes specialized metabolic networks (for brain and 3 other tissues) for computationally identifying metabolomic changes that correlate with gene expression or genetic differences. To stimulate other investigators to make genetic discoveries, all results and methods from this project will be made fully available to the scientific community. These computational tools will be used to analyze customized `multi-omic' (genetic, transcriptional, and metabolomic) datasets that measure: (i) fifteen responses of inbred strain panels to four DOA (cocaine, methamphetamine, fentanyl, and nicotine); and (ii) corresponding DOA- induced transcriptional and metabolomic changes in brain. Integrated analysis of this data will identify genes/pathways affecting the response to DOA. We then apply a high efficiency method for engineering specific allelic changes into the genome of inbred strains, and the engineered lines are used to experimentally test the effect of an identified genetic factor on the response to a DOA.